COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England

Marion Mafham(Nuffield Health), Colin Baigent(University of Oxford), Eva Morris(Open Data Institute), Raph Goldacre(Open Data Institute), John Deanfield(Universidad de Londres), Paula Curnow(NHS Digital), T F Luescher(Imperial College London), Sam Hollings(NHS Digital), Dominic Gair(NHS Digital), Chris P Gale(University of Leeds), Mark de Belder(NIHR Research Delivery Network), Mamas A. Mamas(University Hospitals of North Midlands NHS Trust), Tom Denwood(NHS Digital), Barbara Casadei(John Radcliffe Hospital), Chris Roebuck(NHS Digital), Martin Landray(Gentofte Hospital), Rory Collins(University of Oxford), Enti Spata(Medical Research Council), Mark Bray(NHS Digital), Jonathan Emberson(University of Oxford)
The Lancet
July 14, 2020
10.1016/s0140-6736(20)31356-8
Cited by 747

Related Papers

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
|The Lancet|1992|4.8k
Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery
|Journal of the American College of Cardiology|2002|4.6k
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
|The Lancet|2003|3.8k
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
|The Lancet|2015|3.7k
Atherosclerosis
|Nature Reviews Disease Primers|2019|3k